For the hosts, Sejaro and Semavik developed a support app

In the Russian market debuted the application Stroynee. It is the first solution that combines reference information on GLP-1-based drugs for weight correction and applied tools focused on stable weight loss.

The company GEROPHARM said that the service is adapted for patients receiving therapy with Sejaro, Semavik and Semavik Next: specialized educational modules and an expanded set of functions have been developed for them.

This is reported by newstula.ru. With the help of the application, the user can not only fix the dosage and adhere to the injection schedule, but also track the diet, the amount of physical activity, as well as the dynamics of emotional well-being.

At the disposal of users are training materials prepared by practitioners and industry experts, as well as a series of video trainings conducted by Olympic champion Irina Slutskaya. The motivational component in the application is enhanced by game mechanics: the “hero card” with daily tasks and a reward system is designed to maintain the patient’s involvement and help maintain a given rhythm of work on yourself. Experts emphasize that the combination of medical support, educational elements and behavioral tools allows not only to achieve weight loss, but also to form stable healthy habits, while mitigating the psychological stress that often accompany the process of therapy.

Scientific evidence confirms the effectiveness of mobile solutions for weight control: published the findings of an international group of researchers. According to the analysis, the use of mobile applications correlates with a statistically significant and prolonged decrease in body weight and waist circumference. At the same time, traditional web platforms with similar functionality do not show comparable results. The decisive advantage of the mobile format is the continuous availability of control and support, allowing the patient to remain in the track at any time.

GEROPHARM CEO Peter Rodionov explained that the key task of integrating digital tools is to overcome the psychological barriers that make it difficult to start and maintain therapy. Such obstacles include, inter alia, the anxiety associated with the need for injections and the lack of orderly, understandable information on the topic of treatment. The expanded digital environment should help patients move toward their goals predictably and measurably, making the therapeutic process more transparent and controllable.